)
)
)
Tacit Therapeutics
Our Splicing-Directed Repair™ platform is a non-immunogenic and broadly-applicable way to repair mutations. Our technology is based upon a type of RNA trans-splicing that utilizes the endogenous spliceosome to repair multiple kilobases of RNA.
){kind=logo}
)